Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation-Reference-Cited by-同舟云学术

Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation

Published:2014-10-30 Issue:23 Volume:13 Page:3727-3741
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Podszywalow-Bartnicka Paulina,Wolczyk Magdalena,Kusio-Kobialka Monika,Wolanin Kamila,Skowronek Krzysztof,Nieborowska-Skorska Margaret,Dasgupta Yashodhara,Skorski Tomasz,Piwocka Katarzyna

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/15384101.2014.965013

Reference40 articles.

1. Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia

2. Fusion tyrosine kinases: a result and cause of genomic instability

3. Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cells

4. Expression of Oncogenic Kinase Bcr-Abl Impairs Mitotic Checkpoint and Promotes Aberrant Divisions and Resistance to Microtubule-Targeting Agents

5. BCR-ABL Hits at Mitosis; Implications for Chromosomal Instability, Aneuploidy and Therapeutic Strategy

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of mutation-independent BRCA2 protein deficiency expands diagnostics and selection of pancreatic cancer patients for personalized therapy with PARP1 inhibitors;2024-09-08

2. Multiple roles for AU-rich RNA binding proteins in the development of haematologic malignancies and their resistance to chemotherapy;RNA Biology;2024-05-27

3. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies;Blood;2024-05-23

4. Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors;HemaSphere;2024-03

5. Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations;Cell Reports;2023-08